Genentech, Inc. (Jobs) Warns Doctors Of Lucentis Stroke Risk

LOS ANGELES (Reuters) - Genentech Inc. has sent a letter alerting eye doctors to the risk of stroke from Lucentis, its drug for treating age-related macular degeneration, a spokeswoman said on Friday.

>>> Discuss This Story

MORE ON THIS TOPIC